Carlo PAPPONE, MD, PhD
CV Landmarks
Research Activity
(Summary)
Overall Publications (n)
Publications: 294
Citations: 11.815
Cites/Year : 537
Impact Factor > 1000
Landmark Articles
New Engl J Med (4 full text articles) Circulation (14 full text articles)
JACC (15 full text articles) JAMA (1 full text article)
The most important seminal researches I have conducted were on AF ablation (cited in > 10000 peer-reviewed articles), remote navigation and ablation (cited in > 500 peer-peer-reviewed articles) and Wolff-Parkinson White Syndrome (cited in about 500 peer-reviewed articles).
My research activity was mainly focoused
1. Investigation on physiopatology of cardiac arrhythmias.
2. Assessment and treatment modalities for patients with cardiac arrhythmias. 3. Development of innovative ablation strategies for atrial fibrillation. 4. Electrophysiological treatment of patients with heart failure.
5. Biophisics of radiofrequency ablation. Design, experimental evaluation and clinical evaluation of computer assisted tridimensional mapping systems.
6. Design, experimental evaluation and clinical testing of innovative cardiac ablation Catethers.
7.Development,validation and clinical implementation of robotic navigation systems. 8. Partecipation in international multicenter studies.
9. Epicardial ablation in Brugada syndrome.
10. Development of new catheters for multisite pacing in cardiac resynchronization therapy. 11. New tools for rotors identification and ablation in patients with atrial fibrillation.
This activity is documented by the production of groundbreaking papers on the natural history of patients with WPW syndrome and on the effects of prophylactic ablation that have led to major updates in the international guidelines on WPW ablation. Another area of groundbreaking research is the treatment of atrial fibrillation. As documented by several papers, my activity has led to the discovery of major phisiopatological mechanisms of atrial fibrillation, such as the role of vagal innervation and its modification, the identification of areas of different patterns of activation indicating the areas of origin and maintenance of fibrillatory activity. Based on these observations I developed and proposed an ablation approach now recognized as “Pappone approach” and that has become the most used and clinical successful procedure for AF ablation so far. I have partecipated in the early stages of development of all the 3D mapping systems available (Carto, NavX, Velocity, Mediguide) in both the experimental, preclinical and clinical phases and directed the development of the clinical protocols related to their utilization. I have designed new catheter tips and innovative cooling circuits for cardiac
ablation catheters. I also conducted and supervised the experimental and clinical developments of the prototypes until the production of commercial devices and I hold international patents on these catheters. I partecipated to the experimental evaluation and first in man implants of different devices for electrical treatment of heart failure, including different biventricular pacing systems, cardiac contractility modulation devices and multipoint biventricular stimulation in patients with heart failure. This activity is also documented by several publications on high impact medical journals. The partecipation to multicenter clinical studies has also been part of my activity, particularly focused on Atrial Fibrillation Ablation efficacy.
Randomized Multicenter Trials
My secondary focus has been and is the design and implementation of large-scale randomized trials and prospective cohort studies. I have been directly involved in many randomized trials as a principal investigator, consultant, Steering Committee Chair or member. I have been the Principal Investigator of several prospective randomized trials such as the recent APAF Study and a Co-Investigator on many other large-scale trials and observational studies such as the ongoing multicenter CABANA study, which involves many European and USA investigators. I have initiated new single-center research programs in a large number of atrial fibrillation patients with heart disease and comorbidities designed to evaluate arrhythmia progression as well as the effect of catheter ablation on thromboembolism and Quality of Life.
The Pappone Approach
My primary area of interest is the pathophysiology and treatment of patients with atrial fibrillation by interventional electrophysiology and the “Pappone approach” is currently one of the most used strategy to cure atrial fibrillation. I have been the principal investigator in many studies regarding the development and use of the CARTO electroanatomical mapping system for guiding ablation of atrial fibrillation in humans and the first one to perform a mapping study in a human patient in 1994. I have been author of landmark studies on radiofrequency transcatheter ablation for atrial fibrillation published for 3 consecutive years in Circulation, a leading journal in the field of cardiovascular medicine. These studies have been cited in 2.987 peer-reviewed articles. Leading study entitled “Catheter ablation of atrial fibrillation using a 3D mapping system” has itself been cited in 315 articles,
including the guidelines issued by the American Heart Association/American College of Cardiology/European Society of Cardiology for management of patients with atrial fibrillation.
Sudden Death in WPW Syndrome
My interest has been and is currently focused on pathophysiology and prevention of sudden death particularly in patients with WPW syndrome. More recently, my work focuses on the natural history of the syndrome to identify patients at risk of sudden death. The last guidelines (Heart Rhythm, April 2012) have accepted and included the conclusions of our seminal studies.
Catheter ablation of atrial fibrillation
Pulmonary vein denervation as an additional benefit to Pulmonary Vein (PV) isolation was first discovered by my group and published as “fast track article” in Circulation 2004. These seminal data from our group have been confirmed worldwide.
Brugada Syndrome
My recent interest is focused on identification of patients with genetic diseases such as Brugada syndrome at risk of sudden death and more recently, on epicardial ablation to eliminate Brugada syndome pattern. (JACC 2012, Eur Heart J 2009)
Atrioesophageal Fistula
Atrioesophageal fistula after ablation was firstly described by my group and again published in Circulation 2004. Our preliminary results have been confirmed by many other studies. (Circulation 2004)
I have performed successfully the first transatlantic arrhythmia ablation procedure from Boston, while the patient was in Italy, 4.000 miles away. During the annual Heart Rhythm Society Meeting, I performed an AF ablation procedure, by using a simple computer keyboard able to remotely control a magnetically guided ablation catheter. The importance of this event is that new frontiers have been crossed, as physicians can now carry out long-distance heart procedures in any part of the world. This is another significant scientific step forward in mankind welfare. This event can be considered as the beginning of a democratic medicine for everyone, as people living in underdeveloped countries can finally benefit from much more experienced centers by the remote ablative therapy. (JACC 2006, JACC 2008, Eur Heart J 2008, J Cardiovasc Electrophysiol 2007, Heart Rhythm 2011)
Clinical Practice Guidelines Contributor
I have served and I serve on the steering committee for AF ablation management and guidelines. I served as a member of Expert Consensus Group for development of Clinical Practice Guidelines for Catheter and Surgical Ablation of Atrial Fibrillation: 2007, 2009, 2012, 2014 (developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS).
Book Chapters (n.30)
Another interest is the translation of our research findings into clinical setting through comprehensive reviews, book chapters and books.
Current Research Activities
Current research activities include the renal sympathetic nerve ablation in the treatment of refractory hypertension, new catheter design to optimize RF applications in patients with atrial flutter or atrial fibrillation (Coolflex catheter), multipoint-biventricular pacing (Quadra catheter MPP, PV-LOOP catheter) in patients with heart failure. Finally, identification and elimination of rotors in patients with
paroxysmal or persistent atrial fibrillation by new tools and algorithms. Epicardial ablation to eliminate Brugada pattern. New catheter design to perform epicardial ablation in patients with Brugada syndrome.
Awarded in 2005 as Elite Reviewer of JACC
Peer Reviewer Activity
I have served as Reviewer of the American Heart Journal, American Journal of Cardiology, Circulation, Circulation Arrhythmia Electrophysiology, European Heart Journal, Europace, Heart Rhythm, Journal of the American Medical Association, Journal of the American College of Cardiology, Journal of Cardiovascular Electrophysiology, Lancet, Journal of Cardiovascular Medicine, Annals of Internal Medicinem, Giornale Italiano di Cardiologia, Giornale Italiano di Aritmologia e Cardiostimolazione.
Editorial Board
I have served as member of the Editorial Board of the Journal of the American College of Cardiology, Heart Rhythm, Journal of Cardiovascular Medicine, Giornale Italiano di Cardiologia, Giornale Italiano di Aritmologia e Cardiostimolazione.
Commercialization of Patents
System and methods for locating and ablating arrhythomogenic tissues (2007). Electrophysiology catheter and system for gentle and firm wall contact (2007) System and Network for Remote Medical Procedures (2007)
Multi-Electrode Irrigated Balloon Catheter (2008) Irrigated Catheter with Improved fluid flow (2008) Control for a Remote Navigation System (2008) Method of treating cardiac arrhythmias (2010)
Ablation catheter with flexible tip (2012)
New catheter design for cardiac resynchronization therapy in heart failure patients (2013-2015) New tool to identify rotors in atrial fibrillation (ongoing)
New catheter to perform epicardial hot saline infusion (ongoing)
Clinical Activity
My current position is that of Director of the Arrhythmology Department and Electrophysiological activities at San Donato University Hospital, Milan. I personally perform interventional electrophysiological procedures, device implant, appendage occlusion while supervising the activities of the located medical staff. Particular areas of interest are represented by ablation in children, with special interest in the treatment of high risk accessory pathways, interventional electrophysiological treatment of atrial fibrillation, and cardiac resynchronization therpapy with new bi-ventricular pacing catheter design. Most of the techniques currently used for this challenging clinical conditions have been developed through my research activity, based both on the operative procedures and on the development of innovative equipements and catheters.I also perform such procedures in satellite centers training the local staff in order to enable them to perform more complex and demanding procedures while coordinating the clinical and research activities of the group. Before the present position, I had similar position as Director of the Arrhythmology Department and Electrophysiology laboratories at the San Raffaele University Hospital of Milano from 1999 up to December 2009 and at Maria Cecilia Hospital, Cotignola (Ravenna) from January 2010 up to February 2015.
Teaching Activities & Arrhythmology Academy
University of Naples "Federico II" - 1998; University Vita Salute San Raffaele, Milan - 1999, 2000, 2001; University of Ferrara - 2011, 2012, San Donato University Hospital 2015.
I have been personally involved in teaching at achademic level for medical and postgraduate students, in organizing teaching courses for international cardiologists and electrophysiologists, and in training clinical and research electrophysiology fellows in my laboratories. My formal university cardiology courses were held at the San Raffaele University-Hospital in Milan and University of Ferrara for medical students, as well as for the postgraduate cardiology students of the Cardiology Speciality
Medical School of the same universities. In 2005 I founded and directed the Arrhytmology Academy, a teaching organization involving an international top level faculty aimed at providing medical education in the area of interventional electrophysiology to international cardiologists interested to developing their practical skills and theoretical knowledges in this field. I have held 85 courses at the clinical institutions where I practiced, training 992 doctors from 55 countries, organizing focoused courses on ablation, device implant and follo- up, renal artery denervation, epicardial ablation and structural heart disease treatment in the prevention of cardioembolic stroke. In the clinical departments I hosted over 300 clinical and research fellows from Italy and several different countries (United States, United Kingdom, Japan, Brazil, Canada, Egipt) who received hands on interventional training and partecipated to the research activity both in practical research and in medical writing. I have promoted theory and practice through interactive discussion and comments during live procedure demonstration, meetings and lectures. Interactions and partnership in Italy and internationally and collaboration with industries have been also undertaken. The Academy is accredited by the European Society of Cardiology (EBAC).
Professional Associations
Fellow, American College of Cardiology Fellow, Heart Rhythm Society Member, Council on Clinical Cardiology, American Heart Association Honorary Member, Russian Society for Cardiac Pacing and Electrophysiology.
CURRICULUM VITAE
Carlo PAPPONE, MD, PhD
Date of Birth: December 5, 1961 Place of Birth: Benevento, Italy
Current Position: Director, Department of Arrhythmology, San Donato University Hospital, San
Donato Milanese (Milan, Italy).
Home Address: Piazza San Giovanni 9, 23870 Cernusco Lombardone (Lecco) (LC) Italy.
Contact Information: Policlinico San Donato, Arrhythmology Department, Piazza E. Malan, 20097,
San Donato Milanese (MI), Italy.
Tel +39 02 52774260 Fax: +39 02 52774306
E-mail: [email protected]
Education
MD Degree: October 29, 1986. School of Medicine, University of Naples, Federico II.
Thesis: “Effects of iloprost in the treatment of acute myocardial infarction.” Score: 110/110 with honors.
Medical Licensure (Italy): 1986. Score: 90/90 with honors.
Cardiology Specialty Degree: 1986-1990. University of Naples Federico II. Thesis: “Transcatheter
radiofrequency ablation of post-infarction ventricular tachycardias.” Score: 70/70 with honors.
Electrophysiology Trainings. 1) 1986-1987 Research Fellowship. Cardiology Department,
University of Naples, Federico II; 2) 1987-1988 Clinical Fellowship. Electrophysiology Laboratory, University of Naples; 3) 1988-89. Interventional Electrophysiology, Hospital Policlinico San Matteo, Pavia; 4) July – September 1991. Division of Cardiology, Univ. of Michigan Medical Center, Ann Arbor; 5) July – August 1992. Division of Cardiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK (Chief: W.M. Jackman, MD)
PhD doctoral studies: 1991-1995. Doctorate in Cardiovascular Pathophysiology, University "Tor
Vergata", Rome. PhD degree Oct. 1995, with honors Thesis: “Transcatheter radiofrequency ablation of atrial tachycardia: mapping techniques.”
Clinical practice as first operator
Total EP studies: >160.000; Ablation procedures: >130.000; PM implantation >50.000; ICD implantation > 20.000; Biventricular PM > 6.000.
Scientific activity
Landmark papers
Total Publications in Medline: 134; Total Impact Factor: > 1000; Citations: > 10.000.
New Engl J Med (4 original articles) Circulation (14 original articles) JACC (15 original articles) JAMA (1 original article)
Major Administrative Leadership Assignments
Director, Electrophysiology laboratory, Università degli Studi Federico II, Napoli. Director, Department of Arrhythmology S. Raffaele University Hospital, Milan.
Responsible of the EP lab, Morgagni Heart Center, Catania. Responsible of the EP lab, Clinic Villa Maria Eleonora, Palermo. Responsible of the EP lab, S. Rocco Clinic, Ome, Brescia.
Responsible of the EP lab, Clinic, Maria Cecilia Hospital, Cotignola.
Director of the Department of Arrhythmology Maria Cecilia Hospital, Cotignola, Ravenna. Director of the Department of Arrhythmology Policlinico San Donato, Milano
Associate Professor, Interventional Electrophysiology, Cardiology fellowship program, University of Naples "Federico II".
Director of the Course on Cardiovascular Diseases, S. Raffaele University-Hospitall, Milan, Italy. Invited Visiting Professor, EP and Pacer Labs, German Heart Center, Munich, Germany
Lecture: “Ablation of Atrial Fibrillation using Carto” Live Demonstration.
Invited Visiting Professor, 5th PragueWorkshop on Catheter Ablation, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic.
Lecture: “Catheter ablation of atrial fibrillation – the Milan experience” Live Demonstration.
Invited Visiting Professor, 10th Anniversary Symposium of the Cardio- Thoracic Clinic, “RestoreRhythm and Contractility”, Bergamansheil, Klinikum der Ruhr,-Universität Bochum.
Live Demonstration: Pulmonary Vein Isolation in a patient with Chronic Atrial Fibrillation using the CARTO system Lecture: “Aspects and results of Pulmonary Vein Isolation in Atrial Fibrillation using
the CARTO- system”.
Academic and Research Appointments
Invited Visiting Professor, University of Michigan, Division of Cardiology, Ann Arbor, MI, USA. Cardiology Grand Rounds Lecture: “Mortality, Morbidity and Quality of Life After Circumferential PV Ablation .Atrial Fibrillation: 50 Years On”
Invited Visiting Professor, Medical College of Virginia, in Richmond, VA, USA
Cardiology Grand Rounds Lecture: “Mortality, Morbidity and Quality of Life After Circumferential PV Ablation.Atrial Fibrillation: 50 Years On”.
Live Demonstration
Invited Visiting Professor, 4th International Workshop for Interventional Electrophysiology, Bakoulev Scientifc Center for Cardiovascular Surgery of Russian academy of Medical Sciences, Moscw, Russia Lecture: “Circumferential Pulmonary Vein Ablation for Atrial Fibrillation: The Milan Experience” Live Demonstration
Invited Visiting Professor, Cardiovascular Department, EP Labs, San Filippo Neri Hospital, Rome, Italy. Director: Prof. Massimo Santini.
Live Demonstration: “Radiofrequency Catheter Ablation for paroxysmal Atrial Fibrillation” Invited Visiting Professor, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Case presentations
Cardiology Grand Rounds: “Ablation for Atrial fibrillation: What’s New and Exciting”
Invited Visiting Professor, USC Keck School of Medicine, University of Southern California, Division of Cardiovascular Medicine Los Angeles, CA, USA
Cardiology Grand Rounds: “Catheter Ablation for Atrial Fibrillation:state of the art and the future” Director of Academy of Arrhythmology under the supervision of the European Society of Cardiology and the Heart Rhythm Society
Invited Visiting Professor in occasion of the annual meeting of Japanese ablation Society. Tsukuba. Japan
Overview and newest technicque of anatomical LA ablation around the Pvs
Invited Visiting Professor, New York Presbyterian Hospital – Weill Medical College of Cornell University – Ney York
Carlo Pappone performed successfully the first transatlantic arrhythmia ablation procedure from Boston, while the patient was in Italy, 4.000 miles away. In front of hundreds of spectators, during the annual Heart Rhythm Society Meeting, Pappone performed an AF ablation procedure, by using a simple computer keyboard able to remotely control a magnetically guided ablation catheter. The importance of this event is that new frontiers have been crossed, as physicians can now carry out long-distance heart procedures in any part of the world. This is another significant scientific step forward in mankind welfare. This event can be considered as the beginning of a democratic medicine for everyone, as people living in underdeveloped countries can finally benefit from much more experienced centers by the remote ablative therapy.
Invited Visiting Professor at SIFA Hospital in Izmir Turky Formal talk on Magnetic Navigation techniques.
Invited Visiting Professor, Clinico San Carlos Madrid Spain C/o Professor Martin Lagos Invited Visiting Professor. Al-Minya University Hospital. Egypt
Lecture: “Catheter ablationfor atrial fibrillation: from present to future”
Opening of the Department of Arrhythmology in Cotignola, Maria Cecilia Hospital. During the opening ceremony, two remote procedures of atrial fibrillation ablation using magnetic navigation system Niobe Stereotaxis were performed by myself. There were two patients, the first patient in Milan (Istituto Clinico città Studi) and the second one in Maria Cecilia Hospital.
Professor of Cardiology Cardiovascular Specialty University of Ferrara
Professional Societies: ESC, HRS, AHA
Editorial Responsibilities
Peer Reviewer (2003-present)
Reviewer and Editorial Board
New England Journal of Medicine, Lancet, Circulation, Journal of the American College of Cardiology (Awarded in 2005 as Elite Reviewer of JACC), American Heart Journal, American Journal of Cardiology, Annals of Internal Medicine, Circulation: Arrhythmia Electrophysiology, European Heart Journal, Europace, Heart Rhythm, Journal of the American Medical Association, Journal of Cardiovascular Electrophysiology, Giornale Italiano di Cardiologia, Journal of Cardiovascular Medicine, Giorn. Italiano di Aritmologia e Cardiostimolazione.
Clinical activity
Prof. Pappone directed the Arrhythmology Department of the University-Hospital San Raffaele, Milan and of Maria Cecilia Hospital, Ravenna. Currently, he is the director of the Arrhythmology Department of San Donato University Hospital, Milan. He usually perform manual or remote ablation procedures for patients all over Italy or worldwide. The innovative remote and manual technologies for curative treatment of all cardiac arrhythmias in patients with heart diseases has an accompanying fellowship and has clinics in many locations involving several faculty members and fellows providing over 3500 ablation procedures per year. In close collaboration with his colleagues at several national centers including but not limited to the University of Ferrara, Messina, Bari, and Catanzaro he is helping to develop new clinical programs in cardiac resynchronization therapy among patients with heart failure as well as in cardiac arrhythmia management particularly in patients with atrial fibrillation and more recently in patients with Brugada syndrome. He is developing an integrated care model where cardiologists, electrophysiologists, generalists and subspecialists work as a team to optimize care for patients with heart diseases.
Participation in Clinical Trials as principal investigator or
co-investigator
1.1994-1998. Principal Investigator in studies regarding the development and use of the CARTO electroanatomical mapping system in humans
2.Dr. Pappone was the first in the world to perform a mapping study in a human patient in 1994
3.1997-present. Principal Investigator in studies involving the use of the CARTO electroanatomical mapping system for guiding ablation of atrial fibrillation
4.1998-present. Main Investigator in trials on biventricular pacing for the treatment of heart failure (Insync and P A TH-CHF)
5.1995-present. Principal Investigator in studies testing the use of a novel form of nonexcitatory current to improve cardiac contractility in patients with heart failure (IMPULSE). Performed the first human acute hemodynamic studies testing the effects of the current between 1997 and 1999. Performed the first chronic implants in 6 patients with heart failure in 2000
6.2002. Co-Investigator in multicenter studies on the natural History of Brugada Syndrome.
7.2003. Co-Investigator in multicenter studies on a new automatic external cardioverter-defibrillator.
8.2004-2005. Principal Investigator of a randomized study in collaboration with the Michigan University- Hospital (USA) on chronic atrial fibrillation and catheter ablation.
9.2005- Co-Investigator on surgical ablation of atrial fibrillation with a novel bipolar radiofrequency device.
10.2005 Principal investigator in personal AF Registry study
11.2005 Principal investigator in personal WPW Registry study
12.2005. Co-Investigator in multicenter studies on the PLAATO System for left atrial appendage closure.
13.2006. Principal Investigator of the randomized APAF study comparing antiarrhythmic drug therapy and catheter ablation in paroxysmal atrial fibrillation.
14.2006. Co-Investigator in multicenter studies on percutaneous closure of the left atrial appendage
15.2008- Co-Investigator in InSync ICD Italian Registry.
16.2008 Co-Investigator of the PRELUDE Registry multicenter study.
17.2008.Principal Investigator in Brugada syndrome by a personal grant of the Healthy Minister.
18.2010-2012. Principal investigator on Cool-flex catheter study in patients with atrial flutter.
19.2008-2009. Co-investigator in ThermoCool AF Trial in collaboartion with Wilber DJ (USA).
20.2011-2012 Principal Investigator of Quadra catheter study.
21.2013-2015. Principal investigator on multipoint biventricular pacing randomized study.
22.2014. Principal investigator on rotor mapping and ablation in patients with atrial fibrillation
23.2014-2015 Principal investigator on epicardial catheter ablation in Brugada syndrome.
Research Area
His primary area of interest is the pathophysiology and treatment of patients with paroxysmal or persistent atrial fibrillation by interventional electrophysiology and the “Pappone approach” is currently one of the most used strategy to cure atrial fibrillation (New Engl J Med 2006, Circulation 2001, Circulation 2002). Pulmonary vein denervation as an additional benefit to PV isolation was first discovered by his group and published as “fast track” in Circulation 2004. Atrioesophageal fistula after ablation was firstly described by his group and published in Circulation 2004. His interest is also focused on pathophysiology and prevention of sudden death particularly in patients with WPW syndrome (New Engl J Med 2003, New Engl J Med 2004, New Engl J Med 2005, Circulation 2005,
Circulation 2012, JACC 2003) or in those with genetic diseases such as Brugada Syndrome (JACC 2012, Eur Heart J 2009). Much of his previous work focused and continues to be focused on the electrical treatment of patients with refractory heart failure and hypertrophic or dilated cardiomyopathy. More recently, Pappone focuses his work on the natural history of untreated patients with ventricular preexcitation to identify those at risk of sudden death. His secondary focus is the design and implementation of large-scale randomized trials and prospective cohort studies. He is directly involved in most of these studies as a principal investigator, Consultant, Steering Committee Chair or member. Pappone has been the Principal Investigator of several prospective randomized trials such as the recent APAF Study and a Co-Investigator on many other large-scale trials and observational studies such as the ongoing multicenter CABANA study, which involves many European and USA investigators. He has initiated new single-center research programs in a large number of atrial fibrillation patients with heart disease and comorbidities designed to evaluate arrhythmia progression as well as the effect of catheter ablation on thromboembolism and Quality of Life. He serves on the steering committee for AF ablation management and guidelines. A tertiary interest is the translation of our research findings to the clinical setting through comprehensive reviews, book chapters and books. More recently, randomized trials have been conducted to evaluate the efficacy and safety of multipoint catheter in heart failure patients undergoing cardiac resynchronization therapy.
Groundbreaking Research
1. Authored landmark studies on radiofrequency transcatheter ablation for atrial fibrillation published for 3 consecutive years in Circulation, a leading journal in the field of cardiovascular medicine. These studies have been cited in 2.987 peer-reviewed articles. Leading study entitled “Catheter ablation of atrial fibrillation using a 3D mapping system” has itself been cited in 315 articles, including the guidelines issued by the American Heart Association/American College of Cardiology/European Society of Cardiology for management of patients with atrial fibrillation.
2. Conducted seminal research on cardiovascular diseases, physiopathology antiarrhythmic drug therapy, asymptomatic Wolff-Parkinson White Syndrome, vagal denervation in patients undergoing AF ablation, remote navigation and ablation, progression of AF, the electrical treatment of patients with heart failure, including cardiac resynchronization therapy using multisite pacing and the novel
excitatory electrical cardiac contractility modulation signal.
3. His ablation technique and his high-quality team work were mentioned in the article 10 Great Companies in Europe: San Raffaele, from FORTUNE, Feb 4, 2002 by Milton Moskowitz, Robert Levering, in which the San Raffaele was awarded as on the 10 best European places to work, especially in the biomedical research.
4. The article “Circumferential Radiofrequency Ablation of Pulmonary Vein Ostia: A New Anatomic Approach for Curing Atrial Fibrillation”, (see Publications cited in the Science Citation Index ref. #54) earned an Editorial “Pulmonary Vein Ablation in Atrial Fibrillation: Hype or Hope? by Hein J. J. Wellens, MD. Circulation 2000; 102: 2562-2564.
5. The article entitled “Usefulness of Invasive Electrophysiologic Testing to Stratify the Risk of Arrhythmic Events in Asymptomatic Patients With Wolff-Parkinson-White Pattern. Results From a Large Prospective Long-term Follow-up Study”, (see Publications cited in the Science Citation Index ref. #44) earned an Editorial “Asymptomatic Wolff-Parkinson- White Syndrome: is it Time to Revisit Guidelines?” by Derick M. Todd et al., J Am Coll Cardiol, 2003, 41: 245- 48.
6. The article entitled “Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: Outcomes from a controlled nonrandomized long-term study”, (see Publications cited in the Science Citation Index ref. #48) earned an Editorial “Ablation of atrial fibrillation: awaiting the new paradigm” by Kenneth A. Ellenbogen and Mark A. Wood. J Am Coll Cardiol 2003 Jul 16; 42 (2),185-197.
7. The article “A Randomized Study of Prophylactic Catheter Ablation in Asymptomatic Patients with the Wolff–Parkinson–White Syndrome” (see Publications cited in the Science Citation Index ref. #49) was awarded with the Editorial High-Risk Patients with Ventricular Preexcitation — A Pendulum in Motion by Bruce B. Lerman and Craig T. Basson. THE NEW ENGLAND JOURNAL OF MEDICINE, 2003 Nov 6;349: (19) 1787-1789
8. The article “First Human Chronic Experience with Cardiac Contractility Modulation by Non-Excitatory Electrical Currents for Treating Systolic Heart Failure” (see Publications cited in the Science
Citation Index ref. #36) was awarded with the Editorial Comment Nonexcitatory Electrical Currents for Congestive Heart failure: Exciting or Not? by Mevan Wijetunga and S. Adam Strickberger. J Cardiovasc Electrophysiol. 2004: 428-429
9. The article “Radiofrequency Ablation in Children with Asymptomatic Wolff-Parkinson-White Syndrome”. (see Publications cited in the Science Citation Index ref. #39) was awarded with the Editorial Catheter Ablation for Cardiac Arrhythmias by Hein J.J. Wellens. The New England Journal of Medicine. 2004 Sept 16; 351 (12): 1197-2005
10. The summary of the article “Prevention of Iatrogenic Atrial Tachycardia following ablation of Atrial Fibrillation. A prospective randomized study comparing circumferential pulmonary vein ablation with a modified approach.” (see Publications cited in the Science Citation Index ref. #42) has been included in the The Journal of Evidence-based Cardiovascular Medicine, which includes summaries of only the 100 best and most useful papers published throughout the world featuring the highest quality original research
11. The article “Circumferential Pulmonary-Vein Ablation for Cronic Atrial Fibrillation”. (see Publications cited in the Science Citation Index ref. #19) was awarded with the Editorial Catheter Ablation of chronic atrial fibrillation- the gap between promise and practice by Mark A. Wood and KA Ellenbogen. The New England Journal of Medicine, 2006;354: 967-968
12. The article “Atrial fibrillation progression and management. A 5-year prospective follow-up study” (see Publications cited in the Science Citation Index ref. #8) earned an Editorial “Prevention of progression of atrial fibrillation: A new indication for catheter ablation?” by H Calkins. Heart Rhythm. 2008; 5 (11): 1508-1509
13.The article “The natural history of asymptomatic ventricular preexcitation. A long-term prospective follow-up study of 184 asymptomatic children” (see Publications cited in the Science Citation Index) was awarded with the editorial “Asymptomatic Wolff-Parkinson-White Syndrome in Children An Unnatural History?” by Seshadri Balaji. J Am Coll Cardiol. 2009; 53: 281-283
14. The article “Asymptomatic ventricular preexcitation: A long-term prospective follow-up study of
293 adult patients” earned an Editorial “WPW pattern in the asymptomatic individual. Has anything changed?” by G.J. Klein. Circ Arrhythmia Electrophysiol 2009; 2: 97-99
15. The article “Risk of Malignant Arrhythmias in initially Symptomatic Patients with WPW Syndrome: Results of a Prospective Long-Term Electrophysiological Follow-Up Study. (see Publications cited in the Science Citation Index) was awarded with the editorial “Risk of sudden death in Wolff-Parkinson-White syndrome: how high is the risk?” by Obeyesekere M, Gula
Scientific Interviews and Press
Conferences
2000. Press release, American Heart Association: “A hot tip destroys heart cells, cures atrial fibrillation”. Interview,American College of Cardiology ExtendedLearning (ACCEL) Audiotapes – Circumferential Pulmonary Vein Ablation. A New Anatomic Approach for Curing Atrial Fibrillation.
2001. Press release and conference, Congress of the European Congress of Cardiology.
2001. Atrial fibrillation: is the cure at hand? Interview, American College of Cardiology Extended Learning (ACCEL) Audiotapes – Chronic atrial fibrillation: A Curable condition? 2003.Press release, SorinLifeWatch. “Atrial fibrillation: is the cure at hand?” Interview, American
College of Cardiology Extended Learning (ACCEL) Audiotapes – Chronic atrial fibrillation: A Curable condition?
2006 Interview, American College of Cardiology 55th Annual Scientific Session, Atlanta, GA, USA, March 11- 14, 2006.
Late Breaking Clinical Trial. A Controlled Randomized Trial of Circumferential Pulmonary Vein Ablation Versus Antiarrhythmic Drug Therapy for Curing Paroxysmal Atrial Fibrillation: The
Ablation for Paroxysmal Atrial Fibrillation (AP AF) Trial
2008. Press release and conference, American Heart Association Scientific Sessions 2008. New Orlaeans. November 9-12, 2008. Catheter ablation versus antiarrhythmic drug therapy in
paroxysmal atrial fibrillation. A Long-term Randomized Follow-up Study. The AP AF-2 Study (published in Circulation 2008)
Professional Associations
1 Fellow, American College of Cardiology 2 Fellow, Heart Rhythm Society
3 Member, Council on Clinical Cardiology, American Heart Association
4 Honorary Member, Russian Society for Cardiac Pacing and Electrophysiology
Organization of Scientific Events
1. Updates in Cardiology Meeting: "Technical and Clinical Aspects of a New Rate Responsive Pacing System" Napoli, Oct. 16 1991
2. II Regional Symposium Update in Cardiac Pacing: "Nuovi aspetti del trattamento elettrico delle aritmie cardiache" Napoli, Nov. 22-23, 1991
3. Cardiology Conference: "Non-pharmacological treatment of cardiac arrhythmias: transcatheter ablation and implantable cardioverter defibrillator" Napoli, Nov. 25, 1992
4. Cardiology Conference: "L'ablazione transcatetere a radiofrequenza: aspetti elettrofisiologici e clinici" Napoli, June 11, 1993
5. Course on Theory and Practice of "Radiofrequency Catheter Ablation of Cardiac Arrhythmias" (1st edition). Napoli, April 18-23, 1994. Course Director: Pappone C.
6. Italian Cardiostim Symposium, 9th International Congress Cardiostim '94, Nice, June 15-18, 1994
7. Cardiology 1994, Testi di Aggiornamento e Atti del 28° Convegno Internazionale del Centro A. De Gasperi Ospedale "Ca' Granda" Milano – Riguarda Hospital, Sept. 26-30, 1994
8. 2nd Cardiostim Pan Slavian International Congress on Cardiac Pacing and Electrophysiology. Saint Petersburg, February 2-5, 1995
9. Course on Theory and Practice "Radiofrequency Catheter Ablation of Cardiac Arrhythmias " (2nd edition) Mercogliano, June 26–July 1, 1995
10. Course on Theory and Practice "Radiofrequency Catheter Ablation of Cardiac Arrhythmias" (3rd edition). Milano, July 1-6 1996. HS.Raffaele- International Biomedical Science Park. Course Director: Pappone C.
11. Course on Theory and Practice “Implantation of pacemakers and anti- tachycardia devices”(1st Edition) Milano, 7-9 luglio 1996. HS Raffaele- International Biomedical Science Park. Course Director: Pappone C.
12. Course on Theory and Practice "Radiofrequency Catheter Ablation of Cardiac Arrhythmias" (4th edition). Milano, 23-29 Giugno 1997. HS. Raffaele- International Biomedical Science Park. Course Director: Pappone C.
13. Corso teorico pratico sulla diagnostica e terapia elettrica delle aritmie. Chia 8/10 Luglio 1997 St. Jude Medical Italia S.p.A. Cardiac Rhythm Management Division
14.Ablation therapy for atrial fibrillation. Workshop on Genesi and Management of Cardiac Arrhythmias – International Heart School – Bergamo, Aprile 1998
15. Course on Theory and Practice "Radiofrequency Catheter Ablation of Cardiac Arrhythmias" (5th edition). Milano, 29 Giugno- 3 Luglio 1998. HS.Raffaele – International Biomedical Science Park. Course Director: Pappone C.
16. Course on Theory and Practice "Radiofrequency Catheter Ablation of Cardiac Arrhythmias" (6th edition). Milano, 29 Giugno - 3 Luglio 1999. HS.Raffaele – International Biomedical Science Park. Course Director: Pappone C.
17. Course on Theory and Practice "Radiofrequency Catheter Ablation of Cardiac Arrhythmias" (7th edition) Baveno, June 12-15 2000. HS.Raffaele – International Biomedical Science Park. Course Director: Pappone C.
18. “Ablation of Cardiac Arrhythmias: RF Advanced Course on Theory and Practice” (8th edition). Baveno and Milan, July, 12-15, 2001. Course Director: Pappone C.
19.Course on “Theory and Practice of Catheter Ablation of Atrial Fibrillation" (9th edition). Milan and Naples, April 17-19, 2002 Course Director: Pappone C.
20.International courses and training programs accredited by the European Society of Cardiology (EBAC) – San Raffaele University Hospital – Milan (italy), 2005-2009 Course Director: Pappone C.
21.International courses and training programs accredited by the European Society of Cardiology (EBAC) – Maria Cecilia Hospital – Cotignola (Ra) (Italy), 2010-2012 Course Director: Pappone C.
Teaching material
Videotape: “How to implant biventricular pacemakers in patients with heart failure” (basics and advanced techniques). Editor: Carlo Pappone. Copyright: July 2000.
Video on CD rom: “How to Perform Circumferential Pulmonary Vein Ablation with Electroanatomical Guidance”. Editor: Carlo Pappone. Copyright: Sept. 2000.
Course Syllabus: “Theory and Practice of Catheter Ablation of Atrial Fibrillation 2002”. Editors: Carlo Pappone (Course Director) and Salvatore Rosanio.
DVD Video Collection “Theory and Practice of Catheter Ablation of Atrial Fibrillation. Seven different cases”. Editor: Carlo Pappone. Copyright: December 2002.
DVD Video Stereotaxis “Atrial Fibrillation Ablation”. Editor. Carlo Pappone. Copyright: 2006
DVD Video “Cardiac Resynchronization Therapy”. Editor: Carlo Pappone. Copyright: 2006
DVD Video “Management of Advanced Atrial Fibrillation”. Editor: Carlo Pappone. Copyright: 2011
DVD Video “Stroke Prevention: Left Atrial Appendage Occlusion”. Editor: Carlo Pappone. Copyright: 2011
DVD Video “Circumferential Pulmonary Vein Ablation With MediGuide® System”. Editor: Carlo Pappone. Copyright: 2012
Original Articles in International
Journals
1. Pappone C, Vicedomini G, Manguso F, Baldi M, Petretta A, Giannelli L, Saviano M, Pappone A, Ionescu B, Ciaccio C, Vitale R, Cuko A, Calovic Z, Fundaliotis A, Moscatiello M, Catalano C, Santinelli V. The natural history of Wolff-Parkinson-White syndrome. European Heart Journal Supplements March 2015 17 (Supppl A): A8-A11.
2. Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation.
Brugada J, Pappone C, Berruezo A, Vicedomini G, Manguso F, Ciconte G, Giannelli L, Santinelli V. Circ Arrhythm Electrophysiol. 2015 Aug 19. pii: CIRCEP.115.003220.
3. Pappone C; Ćalović Z; Cuko A; McSpadden LC; Ryu K; Jordan CD; Saviano M; Baldi M; Pappone A; Dozza L; Giannelli L; Fragakis N; Vicedomini G; Santinelli V Multipoint left ventricular pacing provides additional echocardiographic benefit to responders and non-responders to conventional cardiac resynchronization therapy European Heart Journal Supplements March 2015 17 (suppl A): A12-A17.
4. Pappone C, Ćalović Ž, Vicedomini G, Cuko A, McSpadden LC, Ryu K, Jordan CD, Romano E, Baldi M, Saviano M, Pappone A, Vitale R, Catalano C, Ciaccio C, Giannelli L, Ionescu B, Petretta A, Fragakis N, Fundaliotis A, Tavazzi L, Santinelli V.Improving Cardiac Resynchronization Therapy Response with Multipoint Left Ventricular Pacing: 12-month Follow-up Study. Heart Rhythm. 2015 Feb 9. pii: S1547-5271.
5. Pappone C, Ćalović Ž, Vicedomini G, Cuko A, McSpadden LC, Ryu K, Romano E, Baldi M, Saviano M, Pappone A, Ciaccio C, Giannelli L, Ionescu B, Petretta A, Vitale R, Fundaliotis A, Tavazzi L, Santinelli V. Multipoint left ventricular pacing in a single coronary sinus branch improves mid-term echocardiographic and clinical response to cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2015 Jan;26(1):58-63.
6. Anselmino M, Matta M, D'Ascenzo F, Bunch TJ, Schilling RJ, Hunter RJ, Pappone C, Neumann T, Noelker G, Fiala M, Bertaglia E, Frontera A, Duncan E, Nalliah C, Jais P, Weerasooriya R, Kalman JM, Gaita. Response to letter regarding "Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis". Circ Arrhythm Electrophysiol. 2015 Feb;8(1):246.
7. Fragakis N, Antoniadis AP, Saviano M, Vassilikos V, Pappone C. The use of adenosine and adenosine triphosphate testing in the diagnosis, risk stratification and management of patients with syncope: Current evidence and future perspectives. Int J Cardiol. 2015 Jan 30;183C:267-273.
8. Pappone C, Ćalović Ž, Vicedomini G, Cuko A, McSpadden LC, Ryu K, Romano E, Saviano M, Baldi M, Pappone A, Ciaccio C, Giannelli L, Ionescu B, Petretta A, Vitale R, Fundaliotis A, Tavazzi L, Santinelli V. Heart Rhythm. 2014 Mar;11(3):394-401.
9. Pappone C, Vicedomini G, Manguso F, Saviano M, Baldi M, Pappone A, Ciaccio C, Giannelli L, Ionescu B, Petretta A, Vitale R, Cuko A, Calovic Z, Fundaliotis A, Moscatiello M, Tavazzi L, Santinelli V. Wolff-Parkinson-White syndrome in the era of catheter ablation: insights from a registry study of 2169 patients. Circulation. 2014 Sep 2;130(10):811-9.
10.Anselmino M, Matta M, D'Ascenzo F, Bunch TJ, Schilling RJ, Hunter RJ, Pappone C, Neumann T, Noelker G, Fiala M, Bertaglia E, Frontera A, Duncan E, Nalliah C, Jais P, Weerasooriya R, Kalman JM, Gaita F. Catheter ablation of atrial fibrillation in patients with left
ventricular systolic dysfunction: a systematic review and meta-analysis. Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1011-8.
11.Stabile G, Bertaglia E, Pappone A, Themistoclakis S, Tondo C, Calzolari V, Bottoni N, Arena G, Rebellato L, Del Greco M, De Simone A, Corò L, Avella A, Anselmino M, Pappone C. Low incidence of permanent complications during catheter ablation for atrial fibrillation using open-irrigated catheters: a multicentre registry. Europace. 2014 Aug;16(8):1154-9.
12.Themistoclakis S, Raviele A, China P, Pappone C, De Ponti R, Revishvili A, Aliot E, Kuck KH, Hoff PI, Shah D, Almendral J, Manolis AS, Chierchia GB, Oto A, Vatasescu RG, Sinkovec M, Cappato R; Atrial Fibrillation Survey Investigators. Prospective European survey on atrial fibrillation ablation: clinical characteristics of patients and ablation strategies used in different countries. J Cardiovasc Electrophysiol. 2014 Oct;25(10):1074-81.
13.Arbelo E, Brugada J, Hindricks G, Maggioni AP, Tavazzi L, Vardas P, Laroche C, Anselme F, Inama G, Jais P, Kalarus Z, Kautzner J, Lewalter T, Mairesse GH, Perez-Villacastin J, Riahi S, Taborsky M, Theodorakis G, Trines SA; Atrial Fibrillation Ablation Pilot Study Investigators.
The atrial fibrillation ablation pilot study: a European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association.
Eur Heart J. 2014 Jun 7;35(22):1466-78.
14.Boriani G, Berti E, Belotti LM, Biffi M, Carboni A, Bandini A, Casali E, Tomasi C, Toselli T, Baraldi P, Bottoni N, Barbato G, Sassone B; RERAI (Registry of Emilia Romagna on Arrhythmia Interventions) Investigators. Cardiac resynchronization therapy: implant rates, temporal trends and relationships with heart failure epidemiology. J Cardiovasc Med (Hagerstown). 2014 Feb;15(2):147-54.
15.Bertaglia E, Stabile G, Pappone A, Themistoclakis S, Tondo C, De Sanctis V, Soldati E, Tritto M, Solimene F, Grimaldi M, Zoppo F, Pandozi C, Augello G, Calò L, Pappone C. Updated national multicenter registry on procedural safety of catheter ablation for atrial fibrillation.J
Cardiovasc Electrophysiol. 2013 Oct;24(10):1069-74.
16.Sommariva E, Pappone C, Martinelli Boneschi F, Di Resta C, Rosaria Carbone M, Salvi E, Vergara P, Sala S, Cusi D, Ferrari M, Benedetti S. Genetics can contribute to the prognosis of Brugada syndrome: a pilot model for risk stratification. Eur J Hum Genet. 2013 Sep;21(9):911-7.
17.Ierna S, Biondi-Zoccai G, Bachis C, Occhipinti M, Di Vito L, Ricciardi A, Pappone C, Prati F.Transcatheter renal sympathetic ablation for resistant hypertension: in vivo insights in humans from optical coherence tomography. Int J Cardiol. 2013 May 10;165(2):e35-7.
18.Raviele A, Natale A, Calkins H, Camm JA, Cappato R, Ann Chen S, Connolly SJ, Damiano R Jr, DE Ponti R, Edgerton JR, Haïssaguerre M, Hindricks G, Ho SY, Jalife J, Kirchhof P, Kottkamp H, Kuck KH, Marchlinski FE, Packer DL, Pappone C, Prystowsky E, Reddy VK, Themistoclakis S, Verma A, Wilber DJ, Willems S; Venice Chart. Venice Chart international consensus document on atrial fibrillation ablation: 2011 update. J Cardiovasc Electrophysiol. 2012 Aug;23(8):890-923.
19. Arbelo E, Brugada J, Hindricks G, Maggioni A, Tavazzi L, Vardas P, Anselme F, Inama G, Jais P, Kalarus Z, Kautzner J, Lewalter T, Mairesse G, Perez-Villacastin J, Riahi S, Taborsky M, Theodorakis G, Trines S; Atrial Fibrillation Ablation Pilot Study Investigators ESC-EURO bservational Research Programme: the Atrial Fibrillation Ablation Pilot Study, conducted by the European Heart Rhythm Association. Europace. 2012 Aug;14(8):1094-103.
20.Pappone C, Santinelli V. Atrial fibrillation ablation. Rev Esp Cardiol (Engl Ed). 2012 Jun;65(6):560-9.
21. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone
C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012 Apr;14(4):528-606.
22.Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D; Heart Rhythm Society Task Force on Catheter and Surgical Ablation of Atrial Fibrillation.2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm. 2012 Apr;9(4):632-696.e21.
23.Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy
PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol. 2012 Mar;33(2):171-257.
24.Pappone C, Santinelli V. Asymptomatic Wolff-Parkinson-White Syndrome should be ablated. Cardiac Electrophysiology Clinics 2012, 4:281-285
25.Raviele A; Natale A; Calkins H; Camm JA; Cappato R; Ann Chen S; Connoly SJ; Damiano R; De Ponti R; Edgerton JR; Haïssaguerre M; Hindricks G; Ho SY; Jalife J; Kirchhof P; Kottkamp H; Kuck KH; Marchlinski FE; Packer DL; Pappone C; Prystowsky E; Reddy VK; Themistoclakis S; Verma A; Wilber DJ; Willems S. Venice Chart International Consensus Document on Atrial Fibrillation Ablation: 2011 Update. Journal of Cardiovascular Electrophysiology 2012 Aug;23(8):890-923
26.Pappone C, Santinelli V. Post ablation left atrial tachycardia: Understanding mechanism, prevention and teatment. Journal of Atrial Fibriillation 2012, 5 (2):23-31
27.Sommariva E, Vatta M, Xi Y, Sala S, Ai T, Cheng J, Pappone C, Ferrari M, Benedetti S. Compound heterozygous SCN5A gene mutations in asymptomatic Brugada syndrome child. Cardiogenetics 2012, vol.2: e11, 53-58
28.Pappone C, Vicedomini G, Manguso F, Baldi M, Pappone A, Petretta A, Vitale R, Saviano M, Ciaccio C, Giannelli L, Calovic Z, Tavazzi L, Santinelli V. Risk of Malignant Arrhythmias in Initially Symptomatic Patients with WPW Syndrome: Results of a Prospective Long-Term Electrophysiological Follow-Up Study. Circulation. 2012 ;125:661-8. Impact factor: 14.429
29.Priori SG, Gasparini M, Napolitano C, Della Bella P, Ottonelli AG, Sassone B, Giordano U, Pappone C, Mascioli G, Rossetti G, De Nardis R, Colombo M. Risk stratification in Brugada Syndrome: results of the PRELUDE Registry. J Am Coll Cardiol. 2012; 59:37-45. Impact factor
14.292. Impact factor 14.292.
30.Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D (2012). 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012 Apr;14(4):528-606
31.Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D, Heart Rhythm Society Task Force on Catheter and Surgical Ablation of Atrial Fibrillation (2012). 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm 2012
Apr;9(4):632-696.
32.Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D (2012). 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Journal of Interventional Cardiac Electrophysiology 2012 Mar;33(2):171-257.
33.Marangoni S, Di Resta C, Rocchetti M, Barile L, Rizzetto R, Summa A, Severi S, Sommariva E, Pappone C, Ferrari M, Benedetti S, Zaza A. A Brugada syndrome mutation (p.S216L) and its modulation by p.H558R polymorphism: standard and dynamic characterization. Cardiovasc Res. 2011;91:606-16.
34.Carpi F, Kastelein N, Talcott M, Pappone C. Magnetically controllable gastrointestinal steering of video capsules. IEEE Trans Biomed Eng. 2011; 58: 231-234.
35.Wilber DJ, Pappone C, Neuzil P, De Paola A, Marchlinski F, Natale A, Macle L, Daoud EG, Calkins H, Hall B, Reddy V, Augello G, Reynolds MR, Vinekar C, Liu CY, Berry SM, Berry DA; ThermoCool AF Trial Investigators. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA 2010; 303:333-40.
36.Pappone C, Vicedomini G, Cremonesi A, Zuffada F, Santinelli V. Device-based left atrial appendage closure. Circulation AE. 2011 ;4:418-9.
Pappone A, Crisà S, Petretta A, Santinelli V. Irrigated-tip magnetic catheter ablation of AF: a long-term prospective study in 130 patients. Heart Rhythm. 2011;8:8-15.
38.Pappone C, Vicedomini G, Augello G, Manguso F, Saviano M, Baldi M, Petretta A, Giannelli L, Calovic Z, Guluta V, Tavazzi L and Santinelli V. Radiofrequency catheter ablation and antiarrhythmic drug therapy. A prospective, randomized 4-year follow-up trial. The APAF study Circulation AE. 2011;4: 808-14.
39.Augello G, Vicedomini G, Saviano M, Crisa S, Mazzone P, Ornago O, Zuffada F, Santinelli V, Pappone C. Pulmonary vein isolation after circumferential pulmonary vein ablation: comparison between Lasso and three-dimensional electroanatomical assessment of complete electrical disconnection. Heart Rhythm. 2009;6: 1706-13.
40.Santinelli V, Radinovic A, Manguso F, Vicedomini G, Gulletta S, G Paglino, Mazzone P, Ciconte G, Sacchi S, Sala S, Pappone C. The natural history of asymptomatic ventricular preexcitation. A long-term prospective follow-up study of 184 asymptomatic children. J Am Coll Cardiol. 2009; 53: 275-280.
41.Pappone C and Santinelli V. How far have we come? Rev Esp Cardiol. 2009; 62 : 1087-1091.
42.Pappone C, Radinovic A, Manguso F, Vicedomini G, Sala S, Sacco FM, Ciconte G, Saviano M, Ferrari M, Sommariva E, Sacchi S, Ciaccio C, Santinelli V. New-onset atrial fibrillation as first clinical manifestation of latent Brugada syndrome. Prevalence and clinical significance. Eur. Heart J. 2009; 30: 2985-92.
43.Carpi F, Pappone C. Stereotaxis Niobe® magnetic navigation system: achievements and challenges for endocardial catheter ablation and gastrointestinal capsule endoscopy. Expert Reviews Medical Devices 2009;6: 487-498.
44.Carpi F. and Pappone C. Magnetic manoeuvring of endoscopic capsules by means of a robotic navigation system. IEEE Trans Biomed Eng 2009; 56: 1482-1490.
45.Santinelli V, Radinovic A, Manguso F, Vicedomini G, Ciconte G, Gulletta S, Paglino G, Sacchi S, Sala S, Ciaccio C, Pappone C. Asymptomatic ventricular preexcitation: A long-term prospective follow-up study of 293 adult patients. Circ Arrhythmia Electrophysiol 2009; 2:102-107.
46.Pappone C, Radinovic A, Manguso F, Vicedomini G, Ciconte G, Sacchi S, Mazzone P, Paglino G, Gulletta S, Sala S, Santinelli V. Atrial fibrillation progression and management. A 5-year prospective follow-up study. Heart Rhythm. 2008; 5: 1501-1507.
47.Carpi F and Pappone C. Magnetic robotic manoeuvring of gastrointestinal video capsules: preliminary phantom tests. Biomed Pharmacother. 2008; 62: 546-549.
48..Pappone C and Santinelli V. Ablation of atrial fibrillation. Eur Cardiovasc Disease. 2008; 4 : 96-98
49..Pappone C and Santinelli V. Remote ablation of accessory pathways. Eur Heart J. 2008; 29: 422.
50.Pappone C. and Santinelli V. Safety and efficacy of remote magnetic ablation for atrial fibrillation. J Am Coll Cardiol. 2008;51: 1614-1615.
51.Pappone C, Radinovic A and Santinelli V. Sudden death and ventricular preexcitation: is necessary to treat the asymptomatic patients? Curr Pharmac Design. 2008; 14 (8) 762-765. Review
52.Pappone C, Augello G, Gugliotta F, Santinelli V. Robotic and magnetic navigation for atrial fibrillation ablation. How and why? Expert Rev Med Devices. 2007 Nov;4(6):885-894. Review
53.Pappone C, Santinelli V. Non-fluoroscopic mapping as a guide for atrial ablation: current status and expectations for the future. Eur Heart J Supplements 2007; 9: Suppl 1, 1136-1147.
54.Pappone C and Santinelli V. Remote navigation and ablation of atrial fibrillation. J Cardiovasc Electr 2007; 18: S18-S20. Suppl 1.
55.Pappone C and Santinelli V. Mapping and ablation: a worldwide perspective. J. Interv. Card. Electr. 2006 Dec; 17 (3):195-198. Review
56.Pappone C, Vicedomini G, Manguso F, Mazzone P, Gugliotta F, Sala S, Sora N, Paglino G, Gulletta S, Ciaccio C, Tortoriello V, Del Torchio S, Santinelli V. Robotic Magnetic Navigation for Atrial Fibrillation Ablation. J Am Coll Cardiol. 2006 Apr 7;47 (7): 1390-400.
57.Oral H, Pappone C (both, first Authors), Chugh A, Good E, Bogun F, Pelosi F, Bates E , Lehmann M, Vicedomini G, Augello G, Agricola E, Sala S, Santinelli V, Morady F. Circumferential pulmonary vein ablation for chronic atrial fibrillation: a randomized, controlled study. The New Engl J Med 2006 2;354:934-941.
58.Oral H, Pappone C, Morady F. Circumferential pulmonary vein ablation for atrial fibrillation – Reply. The New Engl J Med 2006 2;354: 2290-2291.
59.Pappone C, Santinelli V. Substrate ablation in treatment of atrial fibrillation. J Cardiovasc Electr 2006 17: S23-S27, Suppl: 3.
60.Pappone C and Santinelli V. How to perform encircling ablation of the left atrium. Heart Rhythm. 2006; 3 :1105-1109. Review
61.Pappone C, Santinelli V. Multielectrode basket catheter: A new tool for curing atrial fibrillation. Heart Rhythm 2006; 3:385-386.
62.Pappone C The AP AF study: A controlled randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy for curing paroxysmal atrial fibrillation: The ablation for paroxysmal atrial fibrillation (APAF) trial. HERZ
2006; 31 (2):166
63.Pappone C, Santinelli V. Ablation of atrial fibrillation. Curr Cardiol Rep. 2006 ;8:343-6. Review
64.Lang CC, Gugliotta F, Santinelli V, Mesas C, Tomita T, Vicedomini G, Augello G, Gulletta S, Mazzone P, De Cobelli F, Del Maschio A, Pappone C. Endocardial impedance mapping during circumferential pulmonary vein ablation of atrial fibrillation differentiates between atrial and venous tissue. Heart Rhythm. 2006; 3: 171-178.
65.Mesas C.E, Augello G, Edward Lang,C.C, Gugliotta F, Vicedomini, G, Sora N, De Paola A.A.V, Pappone C. Electroanatomic remodeling of the left atrium in patients undergoing repeat pulmonary vein ablation: Mechanistic insights and implications for ablation. J Cardiovasc Electrophysiol. 2006, 17 : 1279- 1285.
66.Pappone C, Augello A, Sala S, Gugliotta F, Vicedomini G, Gulletta S, Paglino G, Mazzone P, Sora N, Greiss I, Santagostino A, LiVolsi L, Pappone N, Radinovic A, Manguso F and Santinelli V. A Randomized Trial of Circumferential Pulmonary Vein Ablation versus Antiarrhythmic Drug Therapy in Paroxysmal Atrial Fibrillation. The Ablation for Paroxysmal Atrial Fibrillation (APAF) Study. J Am Coll Cardiol. 2006;48:2340-2347.
67. Lang CC, Santinelli V, Augello G, Gulleta S, Sala S, Vicedomini G, Mazzone P, Pappone C Transcatheter Radiofrequency Ablation of atrial fibrillation in patients with mitral valve prosthetes and enlarged atria:safety, feasibility and efficacy. J Am Coll Cardiol. 2005; 45:868– 872.
68.Triedman J, Perry J, Van Hare G, Pappone C, Santinelli V. Risk Stratification for Prophylactic Ablation in Asymptomatic Wolff–Parkinson– White Sindrome. The New Engl J Med 2005; 352: 92-93.
69.Pappone C and Santinelli V. Towards a unified strategy for Atrial Fibrillation? Eur Heart J. 2005; 26:1687-1688.
70.Pappone C and Santinelli V. Catheter ablation should be performed in asymptomatic patients with Wolff-Parkinson-White syndrome. Circulation. 2005; 112:2207-2215.
71.Pappone C and Santinelli V. Atrial fibrillation ablation: a realistic alternative to pharmacologic therapy. Nat Clin Pract Cardiovasc Med. 2005;2:608-609.
72.Pappone C and Santinelli V. Atrial fibrillation ablation: state of the art. Am J Cardiol. 2005; 96(12 A): 59-64. Review
73.Pappone C, Santinelli V, Manguso F, Vicedomini G, Gugliotta F, Augello G, Mazzone P, Tortoriello V, Landoni G, Zangrillo A, Lang C, Tomita T, Mesas C, Mastella E, Alfieri O. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmalatrialfibrillation Circulation. 2004;109: 327-334.
74.Pappone C, Augello G, Rosanio S, Vicedomini G, Santinelli V, Romano M,Agricola E, Maggi F, Buchmayr G, Moretti G, Mika Y, Ben-Haim SA, Wolzt M, Stix G, Schmidinger H. First human chronic experience with cardiac contractility modulation by non-excitatory electrical currents for treating systolic heart failure. J. Cardiovasc. Electr. 2004; 15: 418-427.
75.Pappone C, Oral H, Santinelli V, Vicedomini G, Lang CC, Manguso F, Torracca L, Benussi S, Alfieri O, Hong R, Lau W, Hirata K, Shikuma N, Hall B, Morady F. Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation. 2004 : 109 :2724-26.
76.Mesas CE, Pappone C, Lang CC, Gugliotta F, Tomita T, Vicedomini G, Sala S, Paglino G, Gulletta S, Ferro A, Santinelli V. Left atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation: Electroanatomic characterization and treatment. J Am Coll Cardiol. 2004; 44 : 1071-1079.
77.Pappone C, Manguso F, Vicedomini G, Sala S, Paglino G, Mazzone P, Lang CC, Gulletta S, Augello G,Santinelli V. Radiofrequency Ablation in Children with Asymptomatic
Parkinson-White Syndrome. The New Engl J Med 2004; 351:1197-1205.
78.Pappone C and Santinelli V. Prevention of Atrial Fibrillation: How important is transseptal atrial conduction in humans? J Cardiovasc Electr. 2004; 15: 1118-1119.
79.Pappone C and Santinelli V. The who, what, why, and how-to guide for circumferential pulmonary vein ablation. J Cardiovasc Electrophysiol. 2004;15 :1226-1230.
80.Pappone C, Vicedomini G and Santinelli V. Prevention of Iatrogenic Atrial Tachycardia following ablation of Atrial Fibrillation. A prospective randomized study comparing circumferential pulmonary vein ablation with a modified approach. Circulation. 2004 ; 110: 3036-3042.
81.Pappone C, Santinelli V. Segmental pulmonary vein isolation versus the circumferential approach: Is the tide turning? Heart Rhythm 2004;1:326- 328.
82.Pappone C, Santinelli V, Rosanio S, Vicedomini G, Nardi S, Pappone A, Tortoriello V, Manguso F, Mazzone P, Gulletta S, Oreto G, Alfieri O. Usefulness of invasive electrophysiologic testing to stratify the risk of arrhithmic events in asymptomatic patients with Wolff-Parkinson-White Pattern. Results from a large prospective long-term follow-up.study. J Am Coll Cardiol. 2003; 41, 2: 239-244.
83.Pappone C, Pulmonary Vein Stenosis after Catheter Ablation for Atrial Fibrillation. J Cardiovasc Electrophysiol 2003;14 : 165-167.
84.Pappone C, Rosanio S. Evolution of non-pharmacological curative therapy for atrial fibrillation. Where do we stand today? Int J Cardiol. 2003 ; 88: 135- 142. Review
85.Pappone C, Vicedomini G, Augello G, Nardi S, Mazzone P, Rosanio S. Combining electric therapies for advanced heart failure: The Milan experience with biventricular pacing-defibrillation backup combination for primary prevention of sudden cardiac death. Am J
